Topical Fatty Acid and Tryptophan Composition for Osteoarthritis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for osteoarthritis, such as corticosteroids and NSAIDs, primarily target inflammation rather than its underlying causes, leading to limited effectiveness and significant side effects, while innovative topical treatments for inflammation and osteoarthritis are lacking, especially for smaller joints like hands and feet.
Innovation Solution
Topical compositions comprising a fatty acid, like decanoic acid, and tryptophan, which partition through the skin to inhibit inflammasomes and promote chondrocyte re-differentiation, reducing inflammation and pain by binding to specific sites on inflammasomes and modulating inflammatory pathways.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If topical compositions are applied to smaller joints like hands and feet, then treatment accessibility and reduced trauma are improved, but treatment effectiveness is worsened due to limited surface area for drug delivery
Solution Approach 1:
The patent changes the physical-chemical parameters of the drug delivery system by using a topical composition with specific penetration enhancers and formulation components that enable effective drug delivery through the skin. This allows non-invasive treatment while maintaining therapeutic effectiveness for osteoarthritis in smaller joints.
Solution Approach 2:
The patent introduces intermediary substances including penetration enhancers, solvents, and cosolvents that facilitate the transfer of active ingredients through the skin barrier. These intermediaries enable the active compounds to reach target tissues in smaller joints without requiring invasive injection methods.
2Object-affected harmful factors
If traditional anti-inflammatory drugs like corticosteroids and NSAIDs are used, then inflammation is reduced, but underlying pathological causes are not addressed and side effects increase
Solution Approach 1:
The patent extracts and targets specific inflammatory mediators and pathological pathways underlying osteoarthritis, rather than using broad-spectrum anti-inflammatories. The composition is designed to address root causes including inflammasome activation and cartilage degradation while minimizing off-target effects.
Solution Approach 2:
The patent converts potentially harmful inflammatory processes into beneficial outcomes by using anti-inflammatory compounds that simultaneously promote cartilage protection and repair. The composition transforms the inflammatory response from a harmful pathway into a regulated process that supports tissue healing.
3Adaptability or versatility
If multiple intra-articular steroid injections are administered to treat multi-joint osteoarthritis, then coverage of affected joints is improved, but cumulative trauma and treatment complexity increase
Solution Approach 1:
The patent creates a universal topical composition that can be applied to multiple joints simultaneously, providing broad coverage for polyarticular osteoarthritis. The single formulation serves multiple functions across different joint sizes and locations, eliminating the need for multiple separate injection procedures.
Solution Approach 2:
The patent inverts the traditional treatment approach by applying therapy externally through the skin rather than injecting internally into joints. This reversal of the administration route simplifies treatment from multiple invasive injections to a single non-invasive topical application that can cover multiple joints.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compositions effectively reduce IL-1beta signaling, inhibit inflammasome activation, and promote the re-differentiation of osteoarthritic chondrocytes, providing a safe and effective alternative to traditional treatments for osteoarthritis, particularly for smaller joints.
Implementation Method 1
formulated such that the fatty acid and the tryptophan partition through the skin
Data Source
AI summary
Various aspects of this disclosure relate to topical anti-inflammatory, analgesic compositions comprising a fatty acid and tryptophan as well as methods of using such compositions. In some specific embodiments, the fatty acid is decanoic acid. Such compositions are generally useful to treat inflammation, and they are specifically useful to treat osteoarthritis.